Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP676486.RAfZyPSRiVE3_riloV-8h8FsTfmZyJtOkm2_QTakCc4ik130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP676486.RAfZyPSRiVE3_riloV-8h8FsTfmZyJtOkm2_QTakCc4ik130_assertion type Assertion NP676486.RAfZyPSRiVE3_riloV-8h8FsTfmZyJtOkm2_QTakCc4ik130_head.
- NP676486.RAfZyPSRiVE3_riloV-8h8FsTfmZyJtOkm2_QTakCc4ik130_assertion description "[Low-grade malignancy astrocytomas (grades I-II) showed higher CDH1 expression than did high-grade malignancy astrocytomas (grades III-IV) and medulloblastomas (P < 0.0001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP676486.RAfZyPSRiVE3_riloV-8h8FsTfmZyJtOkm2_QTakCc4ik130_provenance.
- NP676486.RAfZyPSRiVE3_riloV-8h8FsTfmZyJtOkm2_QTakCc4ik130_assertion evidence source_evidence_literature NP676486.RAfZyPSRiVE3_riloV-8h8FsTfmZyJtOkm2_QTakCc4ik130_provenance.
- NP676486.RAfZyPSRiVE3_riloV-8h8FsTfmZyJtOkm2_QTakCc4ik130_assertion SIO_000772 18551395 NP676486.RAfZyPSRiVE3_riloV-8h8FsTfmZyJtOkm2_QTakCc4ik130_provenance.
- NP676486.RAfZyPSRiVE3_riloV-8h8FsTfmZyJtOkm2_QTakCc4ik130_assertion wasDerivedFrom befree-2016 NP676486.RAfZyPSRiVE3_riloV-8h8FsTfmZyJtOkm2_QTakCc4ik130_provenance.
- NP676486.RAfZyPSRiVE3_riloV-8h8FsTfmZyJtOkm2_QTakCc4ik130_assertion wasGeneratedBy ECO_0000203 NP676486.RAfZyPSRiVE3_riloV-8h8FsTfmZyJtOkm2_QTakCc4ik130_provenance.